Matt DeNardo
speaker
183 appearances
1 recordings
1 series
first heard Jul 2026
last heard 11 Jul
Matt DeNardo’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
I think after working in med tech for so long, that's become something that's just baked into my thinking that there is a very long time horizon and more so when you're on the forefront of new technology and new clinical space.
So I think everybody's going into brain computer interfaces, realizing that even the first generation of companies that we all hear about in the news have been working at it for decades.
10 years or more at this point for some of them.
And the clinical studies that you need to support regulatory submissions, the studies themselves can take years.
So it's not surprising in that aspect of just how that's baked into my thinking is that, you know, you go into this knowing that there's a long time horizon to see your device even in use for the first time, nevermind accepted as a regulated medical device.
For me, it's that we're specifically addressing an unmet need that has not really been addressed in any way before.
And I think that...
The fact that it's a brain-computer interface technology makes the technology development exciting, but it's also like the thing that keeps me going day to day is knowing that there are patients out there that in the absence of this technology have very limited options out there to help them, even to help diagnose them in the future or help design treatment plans or to help treat them directly.
And so that kind of guiding principle of there are things that we think we can do to help these patients is what drives me to develop this technology and to make sure it serves their needs once it gets to market.
Sure.
I think that seed was planted back in my first company experience, having done work at Paraguay.
So I think there are a lot of folks who come up in their careers early on without that exposure, and that might not be the first thing that occurs to them, that they have their U.S.-centric blinders on and are looking for how to do the work in the U.S.
And I think...
Being open to the idea that the work can be done somewhere else, just that in itself is a very freeing thought where you now have potentially the whole world available to you depending on the different regulatory restrictions and being able to work with clinical partners in those locations.
We specifically looked at Latin America partially because of my previous experience and because of its proximity to where we are in the Boston area.
And as well that we're looking for a specialty in neurosurgery and that there were centers there with neurosurgery experience that was important to align with because we have a device that's used for neurosurgery.
And so all of those things together said that Latin America is at least a place that we should explore.
And in working through the exploration and ending up selecting a site in Panama as our destination,
clinical trial partners, was driven by the clinicians that we met and were working with at that site.
They had deep neurosurgery experience, had clinical trials experience, and I think were understanding of what we were trying to achieve as a company with this technology.
Showing 41–60 of 183 · page 3 of 10
← Previous
Next →